Latest Regulatory Approvals News

Energy Transition Minerals Ltd (ETM) reported key progress in its December 2025 quarter, including legal developments for its Greenland rare earth project, advancing a strategic mine acquisition in Spain, and moves toward a US Nasdaq listing.

EMVision Medical Devices reports strong progress in its emu™ Brain Scanner clinical trials, expanding recruitment across seven leading stroke hospitals and introducing new software features to enhance scan quality.

Viking Mines has completed a cutting-edge drone survey at its Linka Tungsten Project, integrating 1970s data with modern technology to fast-track exploration and permitting.

Energy Resources of Australia (ERA) reports ongoing legal challenges over the Jabiluka Mineral Lease and a compulsory acquisition court hearing, alongside delays in key rehabilitation works at the Ranger Project Area.

Orezone Gold Corporation has announced its acquisition of the Casa Berardi gold mine in Quebec, Canada, marking a strategic expansion into a Tier 1 mining jurisdiction and significantly boosting its production profile.

Orezone Gold Corporation has announced a transformative acquisition of the Casa Berardi gold mine in Quebec, marking its entry into a Tier 1 mining jurisdiction and significantly boosting production and cash flow.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.

Singular Health Group has advanced its U.S. commercial footprint with the deployment of 500 new licences under its PNS contract and secured FDA clearance for its cloud-based 3DICOM MD® platform, positioning the company for significant growth.

Mont Royal Resources has signed a non-binding Memorandum of Understanding with the Saguenay Port Authority to explore locating a hydrometallurgical facility for its Ashram Rare Earths Project in Québec, leveraging the port’s strategic logistics and industrial infrastructure.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.

Ragusa Minerals has significantly expanded its Purple Pansy Manganese-Gold Project in Arizona by acquiring 201 additional tenements, enhancing its strategic landholding and exploration potential in a critical minerals hotspot.

PC Gold Ltd has secured approvals to re-open the historical Spring Hill underground adit, enabling cost-effective underground drilling to assess high-grade gold mineralisation and potentially expand its resource base.